DAG1 and breast carcinoma: Recently, we have demonstrated that ribitol, a metabolite likely involved in pentose phosphate pathway (PPP) is able to enhance matriglycan levels of α-dystroglycan (α-DG) significantly and dose-dependently in the breast cancer cell line MCF7 and T47D [11].